⌘K

Login Start Free

Home/Filings/4/0001209191-22-022503

4//SEC Filing

Olson Eric R 4

Accession 0001209191-22-022503

CIK 0001556263other

View on SEC.gov Company Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:02 PM ET

Size

4.8 KB

Accession

0001209191-22-022503

Insider Transaction Report

Form 4

Period: 2022-04-01

Syros Pharmaceuticals, Inc.SYRS

Chief Scientific Officer

Transactions

Tax Payment
Common Stock
2022-04-01$1.12/sh−27,266$30,538→ 59,734 total

Footnotes (1)

[F1]Represents shares used to cover tax withholding on a Restricted Stock Unit release.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Syros Pharmaceuticals, Inc.

CIK 0001556263

Entity typeother

Related Parties

1

filerCIK 0001678149

Filing Metadata

Form type: 4
Filed: Apr 3, 8:00 PM ET
Accepted: Apr 4, 5:02 PM ET
Size: 4.8 KB

View on SEC.gov